Immutep Limited

Immutep Limitedverified

PRRUF

Price:

$0.05

Market Cap:

$70.74M

Immutep Limited, an Australian biotechnology firm established in 1987, is focused on the discovery and development of innovative immunotherapeutic pharmaceuticals. The company's pipeline primarily targets cancer and autoimmune diseases. Its flagship product, eftilagimod alpha (also known as efti or IMP321), is currently in a Phase IIb clinical trial, investigating its efficacy as a chemo-immunotherapy combination for metastatic breast cancer. Additional oncology candidates include TACTI-002, undergoing Phase II trials for head and neck squamous cell carcinoma (HNSCC) and non-small cell lung cancer, and TACTI-003, in Phase IIb trials for HNSCC. The company is also evaluating INSIGHT-003 in a ...[Read more]

Industry

Biotechnology

IPO Date

2012-02-22

Stock Exchange

OTC

Ticker

PRRUF

The Current Ratio as of June 2026 (TTM) for Immutep Limited (PRRUF) is 2.97

According to Immutep Limited’s latest financial reports and current stock price. The company's current Current Ratio is 2.97. This represents a change of -77.03% compared to the average of 12.94 of the last 4 quarters.

Immutep Limited (PRRUF) Historical Current Ratio (quarterly & annually)

How has PRRUF Current Ratio performed in the past?

The mean historical Current Ratio of Immutep Limited over the last ten years is 11.26. The current 2.97 Current Ratio has changed 2.54% with respect to the historical average. Over the past ten years (40 quarters), PRRUF's Current Ratio was at its highest in in the June 2011 quarter at 22.49. The Current Ratio was at its lowest in in the December 2007 quarter at 0.

Quarterly (TTM)
Annual

Average

11.26

Median

12.25

Minimum

4.44

Maximum

18.25

Immutep Limited (PRRUF) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Immutep Limited Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 703.63%

Maximum Annual Current Ratio = 18.25

Minimum Annual Increase = -58.92%

Minimum Annual Current Ratio = 4.44

Quarterly (TTM)
Annual
YearCurrent RatioChange
202511.69-35.96%
202418.2532.12%
202313.81-2.44%
202214.1610.50%
202112.8138.37%
20209.26108.42%
20194.44-40.23%
20187.4322.90%
20176.05-58.92%
201614.72703.63%

Immutep Limited (PRRUF) Average Current Ratio

How has PRRUF Current Ratio performed in the past?

The current Current Ratio of Immutep Limited (PRRUF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

14.58

5-year avg

14.14

10-year avg

11.26

Immutep Limited (PRRUF) Current Ratio vs. Peers

How is PRRUF’s Current Ratio compared to its peers?

Immutep Limited’s Current Ratio is greater than Cellectis S.A. (1.52), greater than CytoDyn Inc. (0.37), less than Transgene S.A. (9.62), greater than Northwest Biotherapeutics, Inc. (0.07), less than Clinuvel Pharmaceuticals Limited (14.64), less than Hansa Biopharma AB (publ) (3.63), greater than Frontage Holdings Corporation (1.33), less than Clinuvel Pharmaceuticals Limited (14.64), greater than Healios K.K. (2.05), less than Silence Therapeutics plc (9.83),

Build a custom stock screener for Immutep Limited (PRRUF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Immutep Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Immutep Limited (PRRUF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Immutep Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Immutep Limited's Current Ratio?

How is the Current Ratio calculated for Immutep Limited (PRRUF)?

What is the highest Current Ratio for Immutep Limited (PRRUF)?

What is the 3-year average Current Ratio for Immutep Limited (PRRUF)?

What is the 5-year average Current Ratio for Immutep Limited (PRRUF)?

How does the current Current Ratio for Immutep Limited (PRRUF) compare to its historical average?